Excellent suggestion, @Boffin99
Pros of delisting
- invite potential buyer to anchor any offer to the price history
- the tight registry indicates that limited trading would only mildly inconvenience most shareholders if trading is limited
- there could be opportunities to re-list in the future if needed. And, the US market better knows how to value biotech companies
- keeping "under the radar"
- less costs & compliance of operating on an exchange
Cons of delisting
- no exchange trading (only OTC trading)
- no clear share value
- no analyst coverage, and less interest from investors (specially retail)
I am not saying this is necessarily the right think to do, but it is certainly worth discussing. Thoughts anyone?
I'll add this question to the investor briefing next week.
- Forums
- ASX - By Stock
- RAC
- Industry news
Industry news, page-722
-
- There are more pages in this discussion • 1,091 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.59 |
Change
-0.025(1.55%) |
Mkt cap ! $274.2M |
Open | High | Low | Value | Volume |
$1.60 | $1.60 | $1.59 | $25.79K | 16.13K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 547 | $1.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.60 | 1200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2044 | 1.600 |
1 | 1158 | 1.585 |
4 | 17419 | 1.570 |
1 | 8000 | 1.555 |
4 | 7796 | 1.550 |
Price($) | Vol. | No. |
---|---|---|
1.595 | 2732 | 1 |
1.640 | 200 | 1 |
1.650 | 2839 | 1 |
1.700 | 5000 | 1 |
1.715 | 1100 | 1 |
Last trade - 10.14am 05/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |